Abstract
A seroepidemiological study was conducted on a representative sample of the northern Greek population (healthy individuals, age range=1 day to 80 years) to assess the prevalence of antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA). Antibody concentrations were significantly elevated with age (analysis of variance (ANOVA), P<0.001). In addition, a significant increase in antibody levels was detected in subjects >50 years old compared to children aged 5–10 years (post‐hoc Scheffe analysis, P=0.007). These data suggest that pertussis occurs frequently in Greek adults, and that sometimes a fifth booster vaccine dose is not given after the second year of life. Routine revaccination with the acellular vaccine for children >4 years of age, adolescents, and adults should be considered in order to ensure effective protection of the whole population. J. Clin. Lab. Anal. 18:211–214, 2004. © 2004 Wiley‐Liss, Inc.
Keywords: Bordetella pertussis, immunization, seroepidemiology, pertussis toxin, filamentous hemagglutinin
REFERENCES<
- 1. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000;182:174–179. [DOI] [PubMed] [Google Scholar]
- 2. Kerr JR, Matthews RC. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis 2000;19:77–88. [DOI] [PubMed] [Google Scholar]
- 3. Stojanov S, Liese J, Belohradsky BH. Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection 2000;28:106–110. [DOI] [PubMed] [Google Scholar]
- 4. Saemann‐Ischenko G, Tillmanns B, Kösters K, Riffelmann M, Wirsing von König CH. Stability of antibodies to Bordetella antigens in German adults. Eur J Clin Microbiol Infect Dis 2001;20:850–853. [DOI] [PubMed] [Google Scholar]
- 5. Leef M, Elkins KL, Barbic J, Sharin RD. Protective immunity to Bordetella pertussis requires both B cells and CD4 (+) T cells for key functions other than specific antibody production. J Exp Med 2000;191:1841–1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Piatti G. Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis . FEMS Immunol Med Microbiol 1999;23:235–241. [DOI] [PubMed] [Google Scholar]
- 7. Liederman D, Shvartzman P, Liederman D, et al. Etiology of respiratory tract infection in adults in a German practice setting. Eur J Clin Microbiol Infect Dis 1998;17:685–689. [DOI] [PubMed] [Google Scholar]
- 8. Onorato IM, Wassilak SGF. Laboratory diagnosis of pertussis: the state of the art. Pediatr Infect Dis J 1987;6:145–151. [DOI] [PubMed] [Google Scholar]
- 9. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1–65 years. J Infect Dis 1996;173:1256–1259. [DOI] [PubMed] [Google Scholar]
- 10. Giammanco A, Chiarini A, Stroffolini T, et al. Seroepidemiology of pertussis in Italy. Rev Infect Dis 1991;13:1216–1220. [DOI] [PubMed] [Google Scholar]
- 11. Garcia‐Corbeira P, Dal‐Re R, Aguilar L, Garcia‐de‐Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross‐sectional study. Vaccine 2000;18:2173–2176. [DOI] [PubMed] [Google Scholar]
- 12. Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P. Antibodies against vaccine‐preventable diseases in pregnant women and their offspring in the eastern part of Germany. Med Microbiol Immunol 2002;190:167–172. [DOI] [PubMed] [Google Scholar]
- 13. Lionis C, Chatziarsenis M, Antonakis N, Gianoulis Y, Fioretos M. Assessment of vaccine coverage of schoolchildren in three primary health care areas in rural Crete, Greece. Family Practice 1998;15:443–448. [DOI] [PubMed] [Google Scholar]
- 14. Pournaras S, Tsakris A, Hadjichristodoulou C, et al. Diphtheria immunity of Albanian and other eastern European immigrants in Greece compared with the local population. The risk of reemergence in Greece. Infection 1999;27:361–364. [DOI] [PubMed] [Google Scholar]
- 15. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole‐cell vaccine against pertussis. N Engl J Med 1996;334:341–348. [DOI] [PubMed] [Google Scholar]